Anticancer Agents
AMD473 (ZD0473) exhibits marked in vitro anticancer activity in human tumors
Published in Drug Week, August 1st, 2003
According to a study from the United States, "AMD473 (ZD0473; cis-amminedichloro[2-methylpyridine]-platinum [II]) is a new generation anticancer agent that, in preclinical studies, shows evidence of an extended spectrum of antitumor activity and overcomes platinum resistance mechanisms.
"Here we evaluate the activity of AMD473 (ZD0473) in a panel of 120 human tumor specimens using a soft agar cloning assay (human tumor colony-forming assay). When tumor cells were treated with 1.0, 4.0 or 16.0 micro g/ml AMD473 (ZD0473) for 2 h, in vitro responses were observed in 18%...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2003-08-01)
More Articles from Drug Week
- Drug Design
New possibilities - Attention Deficit Hyperactivity Disorder
Once-daily Adderall XR provides all-day symptom control for children - Cardiac Hypertrophy
Colorado biopharmaceutical company announces cardiac application of HDAC - DNA Research
Patent announced for DNA vaccines with Vaxfectin adjuvant - Infectious Disease Therapy
Azithromycin does not affect cyclosporine A pharmacokinetics after kidney transplantation - Stem Cell Transplantation
Thalidomide has moderate activity against chronic but not acute GVHD - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
